TipRanks
Go Ultimate55% OFF

Compare ImmunoCellular Therapeutics (IMUC) vs. Competitors

187 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
IMUCImmunoCellular Therapeutics$0.05$6.59M-3.42-69.41%―Unlock the IMUC analyst price target with TipRanks PremiumIMUCUnlock the IMUC top-analyst price target with TipRanks Premium
XBIOXenetic Biosciences$1.87$4.71M-1.57-32.67%―Unlock the XBIO analyst price target with TipRanks PremiumIMUC vs XBIOUnlock the XBIO top-analyst price target with TipRanks Premium
ADILAdial Pharmaceuticals$3.81$10.00M-0.30-57.27%Moderate BuyUnlock the ADIL analyst price target with TipRanks PremiumIMUC vs ADILUnlock the ADIL top-analyst price target with TipRanks Premium
INABIN8bio$0.83$9.18M-0.66-49.08%Moderate BuyUnlock the INAB analyst price target with TipRanks PremiumIMUC vs INABUnlock the INAB top-analyst price target with TipRanks Premium
BOLTBolt Biotherapeutics$6.38$12.60M-0.4031.01%NeutralUnlock the BOLT analyst price target with TipRanks PremiumIMUC vs BOLTUnlock the BOLT top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
IMUCImmunoCellular Therapeutics0.05-0.00-7.14%
XBIOXenetic Biosciences1.86-0.86-31.43%
ADILAdial Pharmaceuticals3.81-4.37-53.39%
INABIN8bio0.83-0.83-50.00%
BOLTBolt Biotherapeutics6.381.6033.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts